Abstract
We performed a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials evaluating suvorexant for primary insomnia. Relevant studies were identified through searches of PubMed, databases of the Cochrane Library, and PsycINFO citations through June 27, 2015. We performed a systematic review and meta-analysis of suvorexant trial efficacy and safety outcomes. The primary efficacy outcomes were either subjective total sleep time (sTST) or subjective time-to-sleep onset (sTSO) at 1 month. The secondary outcomes were other efficacy outcomes, discontinuation rate, and individual adverse events. The risk ratio, number-needed-to-treat/harm, and weighted mean difference (WMD) and 95% confidence intervals (CI) based on a random effects model were calculated. The computerized literature database search initially yielded 48 results, from which 37 articles were excluded following a review of titles and abstracts and another eight review articles after full-text review. Thus, we identified 4 trials that included a total of 3,076 patients. Suvorexant was superior to placebo with regard to the two primary efficacy outcomes (sTST: WMD = -20.16, 95% CI = -25.01 to -15.30, 1889 patients, 3 trials, sTSO: WMD = -7.6...Continue Reading
References
May 1, 1990·Journal of Affective Disorders·P TyrerP Riley
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Jul 5, 2001·Sleep Medicine·C H. BastienC M. Morin
Dec 5, 2002·Journal of Sleep Research·Maurice M Ohayon, Markku Partinen
Aug 29, 2003·Journal of Affective Disorders·Dieter Riemann, Ulrich Voderholzer
Apr 25, 2009·The Journal of Clinical Psychiatry·Mark J RapoportNathan Herrmann
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Jul 1, 2011·Addiction·Malcolm Lader
Dec 1, 2012·Neurology·W Joseph HerringDavid Michelson
Oct 23, 2013·The Journal of Clinical Psychiatry·Andrew D KrystalThomas S Kilduff
Jan 10, 2014·Proceedings. Biological Sciences·David M Watson, Mathew Herring
Jan 31, 2014·Frontiers in Neuroscience·Thomas E FitchLinda M Rorick-Kehn
Feb 20, 2014·Frontiers in Neuroscience·Keishi EtoriTakeshi Sakurai
Mar 13, 2014·Frontiers in Neuroscience·Jiann Wei YeohChristopher V Dayas
Mar 25, 2014·Sleep Medicine·Akira KuriyamaYasuaki Hayashino
Apr 1, 2014·Lancet Neurology·David MichelsonW Joseph Herring
May 17, 2014·Frontiers in Neuroscience·Miles D ThompsonJyrki P Kukkonen
Aug 30, 2014·CNS Drugs·Alexander WinklerWinfried Rief
Sep 19, 2014·International Journal of Clinical Practice·L Citrome
Oct 11, 2014·Sleep Medicine Clinics·Adriane M SoehnerAllison G Harvey
Dec 21, 2014·Biological Psychiatry·W Joseph HerringDavid Michelson
May 15, 2015·Journal of Pharmacology & Pharmacotherapeutics·Ashok K DubeyPramod K Mediratta
Citations
Mar 8, 2016·Pharmacology, Biochemistry, and Behavior·Latha Devi, Masuo Ohno
Mar 18, 2016·Der Nervenarzt·G Gründer
May 19, 2017·Journal of Child and Adolescent Psychopharmacology·Kentaro KawabeYasunori Oka
Apr 2, 2017·Psychiatry Research·Matthieu HeinPhilippe Hubain
Sep 19, 2017·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Oliviero BruniRaffaele Ferri
May 9, 2018·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Masakazu HatanoNakao Iwata
Jun 19, 2018·PLoS Medicine·Tracey L SlettenUNKNOWN Delayed Sleep on Melatonin (DelSoM) Study Group
Oct 11, 2017·Disease Models & Mechanisms·Ruchi ChauhanDamian C Crowther
Jul 31, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A D Palman
Feb 23, 2019·Expert Opinion on Pharmacotherapy·Morohunfolu Akinnusi, Ali A El Solh
Oct 20, 2018·Journal of Sleep Research·W Joseph HerringDavid Michelson
Feb 8, 2019·Current Drug Metabolism·Clemens MuehlanJasper Dingemanse
Mar 1, 2018·Pharmacological Reviews·Tobias AtkinGabriella Gobbi
Jun 20, 2016·European Archives of Psychiatry and Clinical Neuroscience·Taro KishiNakao Iwata
Jul 10, 2019·Neuropsychopharmacology Reports·Taro KishiNakao Iwata
Nov 16, 2019·Systematic Reviews·Patricia RiosAndrea C Tricco
Nov 9, 2019·Medicine·Mingming ZhangXiyan Gao
Nov 30, 2019·Neuroscience Bulletin·Ying HanLin Lu
Jun 9, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Jinke HuangYong Huang
Aug 15, 2020·Medicine·Shu XuPeili Wang
Sep 22, 2017·Current Neurology and Neuroscience Reports·Surendra Barshikar, Kathleen R Bell
Oct 23, 2019·Expert Opinion on Pharmacotherapy·Oliviero BruniRaffaele Ferri
Dec 16, 2019·European Journal of Clinical Pharmacology·Judith SysJos Tournoy
Sep 11, 2020·Diabetes Research and Clinical Practice·Fukumi YoshikawaNaoki Kumashiro
Oct 31, 2020·BMJ Open·Atsushi TakahashiHiromasa Ohira
Mar 13, 2021·Expert Opinion on Pharmacotherapy·Gary Zammit, Andrew Krystal
Sep 1, 2021·Advances in Therapy·Hrishikesh P KaleRuth Benca
Sep 1, 2021·Fundamental & Clinical Pharmacology·Subhiksha Subramanian, Mirunalini Ravichandran
Sep 24, 2021·Neuropsychopharmacology Reports·Taro KishiNakao Iwata
Sep 21, 2021·Addiction·David S Baldwin
Nov 25, 2021·Journal of Chemical Information and Modeling·Uta LesselDoris Riether